Antipsychotic Medication and QT Prolongation

Area of Science:

• Cardiology
• Pharmacology
• Psychiatry

Background:

• The QT interval on an electrocardiogram reflects ventricular electrical activity.
• Prolonged QT interval is a risk factor for life-threatening cardiac arrhythmias.
• Medications, particularly antipsychotics, are significant contributors to QT prolongation.

Purpose of the Study:

• To review antipsychotic drugs known to cause QT interval prolongation.
• To elucidate the underlying mechanisms of drug-induced QT prolongation.
• To outline current best practices for managing this adverse effect.

Main Methods:

• Literature review of studies on antipsychotics and QT interval.
• Analysis of reported mechanisms of action related to ion channel function.
• Synthesis of clinical guidelines for patient management.

Main Results:

• Several classes of antipsychotic medications are associated with QT prolongation.
• Mechanisms involve blockade of specific cardiac ion channels (e.g., hERG).
• Risk stratification and vigilant monitoring are crucial.

Conclusions:

• Antipsychotic-induced QT prolongation is a serious, potentially fatal complication.
• Understanding mechanisms aids in risk assessment and drug selection.
• Proactive management is essential to prevent adverse cardiac events.